NewsEarningsFortis Healthcare Reports Robust Q2 FY26 Performance with 17.3% Revenue Growth and Margin ExpansionFortis Healthcare Reports Robust Q2 FY26 Performance with 17.3% Revenue Growth and Margin Expansion
Fortis Healthcare reported consolidated revenue of INR 2,331.00 crores in Q2 FY26, a 17.3% year-on-year increase. Hospital business revenue grew 19.3% to INR 1,974.00 crores, while diagnostics business revenue increased 7.1% to INR 357.00 crores. Operating EBITDA rose 28% to INR 556.00 crores, with margins expanding to 23.9%. Hospital occupancy improved to 71%, and ARPOB increased by 5.8%. The company expanded its network through new agreements and acquisitions, adding 550 operational beds in H1 FY26.
*this image is generated using AI for illustrative purposes only.
Fortis Healthcare , a leading Indian healthcare provider, has reported strong financial results for the second quarter of fiscal year 2026, demonstrating significant growth and improved profitability across its hospital and diagnostics businesses.
Financial Highlights
Fortis Healthcare delivered consolidated revenue of INR 2,331.00 crores in Q2 FY26, marking a 17.3% year-on-year increase. The company's performance was driven by robust growth in both its hospital and diagnostics segments:
| Segment | Revenue (INR Crores) | Growth (YoY) |
|---|---|---|
| Hospital Business | 1,974.00 | 19.3% |
| Diagnostics Business | 357.00 | 7.1% |
The company's operating EBITDA saw a substantial increase of 28% to INR 556.00 crores, with margins expanding to 23.9% from 21.9% in the previous year.
Hospital Business Performance
The hospital business, which accounts for 85% of Fortis Healthcare's consolidated revenue, showed impressive growth:
- Occupancy improved to 71% from 69% in Q1 FY26
- Average Revenue Per Occupied Bed (ARPOB) increased by 5.8% to INR 2.51 crores per annum
- Oncology segment grew by 29% year-on-year, increasing its revenue contribution to 16.2%
- Robotic surgeries increased by 66% year-on-year
Diagnostics Business (Agilus)
Agilus Diagnostics, the company's diagnostics arm, also reported strong performance:
- Gross revenue grew by 7.3% to INR 400.00 crores
- Operating EBITDA margin improved to 26.1% from 21.5% in Q2 FY25
- Conducted 10.6 million tests during the quarter
Expansion and Strategic Initiatives
Fortis Healthcare continues to focus on growth and expansion:
- Entered a 15-year lease agreement for a 200-bed multi-specialty hospital in Greater Noida
- Signed an O&M agreement for a 550-bed greenfield super specialty hospital in Lucknow
- Acquired Shrimann Super Speciality Hospital in Jalandhar, adding 190 operational beds
- Added a total of 550 operational beds in H1 FY26
Management Commentary
Dr. Ashutosh Raghuvanshi, Managing Director and CEO of Fortis Healthcare, stated, "We continue to witness a healthy growth momentum in Q2 FY26 and H1 of FY26. Both our business segments, Hospitals and Diagnostics, continue to perform well both in terms of revenue and margins."
Outlook
With a strong balance sheet and improving operational metrics, Fortis Healthcare appears well-positioned for continued growth. The company's focus on expanding its hospital network, improving occupancy rates, and enhancing its diagnostics capabilities suggests a positive outlook for the coming quarters.
Historical Stock Returns for Fortis Healthcare
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.68% | -4.90% | -12.98% | +37.65% | +45.58% | +565.56% |
16
